An update from InspireMD ( (NSPR)) is now available. InspireMD, Inc., a developer of the CGuard Prime carotid stent system for stroke prevention, reported fourth quarter and full-year 2025 results on ...

(Nasdaq: NSPR) (“InspireMD” or the “Company”), developer of the CGuard ® Prime carotid stent system for the prevention of stroke, today announced financial and operating results for the fourth quarter ...

Q4 2025 Earnings Call March 18, 2026 8:30 AM EDTCompany ParticipantsMarvin Slosman - President, CEO & DirectorMichael Lawless ...

Marvin Slosman, President and CEO, emphasized InspireMD’s momentum in stroke prevention, stating, "I'm extremely proud of our team here at InspireMD and enthusiastic about the impact we are having on ...

In a significant boost to Bangladesh’s healthcare sector, Bangladesh Medical University (BMU) has been accredited as an international training ...

InspireMD Inc. (NASDAQ:NSPR) reported stronger-than-expected fourth-quarter results for 2025, beating both earnings and revenue forecasts as sales accelerated following the U.S. launch of its CGuard ...

A Vizag hospital successfully performs a pioneering hybrid procedure for chronic Type B Aortic Dissection, marking a regional medical milestone.

Guidelines by American College of Cardiology, American Heart Association & other organisations endorse early detection and treatment of dyslipidemia—unhealthy levels of fats in blood.

Someone asked “Doctors, what were the wildest self-diagnoses a patient was actually right about?” and people shared their ...

Hutch Whispered Softly. What deal would probably comment back into recession? Congratulation also from host system build number with real force? Interesting cross cultural negotia ...

Terumo Aortic announced that the FDA has granted Breakthrough Device designation for the company’s fenestrated Treo abdomin ...